Dermatology · San Diego, CA
NPI
1801042502
Since 2008
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5893 Copley Dr
San Diego, CA, 92111
Phone (800) 290-5000
Groups this clinician bills Medicare through
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$1.2M
1,693 prescriptions
Company payments
-
None reported
Medicare prescription drug claims, 2024
In 2024, the drug Julia S Minocha prescribed most often to Medicare patients was Triamcinolone Acetonide, with 153 prescriptions and refills. In total Julia S Minocha wrote 1,693 Medicare prescriptions that cost $1.2M.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-07-15.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Triamcinolone Acetonide Generic | 153 | 170 | 77 | $2,849 |
| Fluorouracil Generic | 147 | 147 | 123 | $5,661 |
| Clobetasol Propionate Generic | 118 | 126 | 56 | $2,818 |
| Cosentyx Sensoready (2 Pens) Secukinumab | 106 | 106 | 11 | $452K |
| Hydrocortisone Generic | 76 | 83 | 42 | $1,132 |
| Calcipotriene Generic | 74 | 76 | 59 | $8,465 |
| Acitretin Generic | 73 | 76 | 13 | $6,549 |
| Doxycycline Monohydrate Generic | 56 | 163 | 26 | $1,845 |
| Tacrolimus Generic | 49 | 55 | 26 | $4,442 |
| Betamethasone Diprop Augmented Betamethasone/Propylene Glyc | 44 | 47 | 24 | $1,710 |
| Valacyclovir Valacyclovir Hcl | 44 | 48 | 12 | $994 |
| Mupirocin Generic | 43 | 43 | 26 | $483 |
| Metronidazole Generic | 43 | 44 | 24 | $842 |
| Ketoconazole Generic | 38 | 45 | 19 | $636 |
| Vectical Calcitriol | 38 | 38 | 36 | $5,810 |
Brand drugs: 352 claims; generic drugs: 1,341 claims.
Money and other things of value reported by the companies
No payments from drug or medical device companies to Julia S Minocha were reported in the years we have.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.